The FDA Grants Premarket Approval To United Therapeutics' LungFX Device For Use In Centralized Ex Vivo Lung Perfusion, A Procedure That Enables Donor Lungs To Be Assessed Outside The Body After Procurement And Before Transplantation

뉴스 본문을 불러오고 있어요.

The FDA Grants Premarket Approval To United Therapeutics' LungFX Device For Use In Centralized Ex Vivo Lung Perfusion, A Procedure That Enables Donor Lungs To Be Assessed Outside The Body After Procurement And Before Transplantation | 웨이프 WAPE

The FDA Grants Premarket Approval To United Therapeutics' LungFX Device For Use In Centralized Ex Vivo Lung Perfusion, A Procedure That Enables Donor Lungs To Be Assessed Outside The Body After Procurement And Before Transplantation

기사 요약

관련 종목

댓글 —